Hiroshi Nakase

62PUBLICATIONS
133CO-AUTHORS
GlycoconjugatesRheumatology and arthritisPredictive and prognostic markersPanel data analysisToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Sep 28, 2026
Effectiveness, safety, and clinical outcomes of treatment with the oral α4-integrin antagonist carotegrast methyl in patients with active ulcerative colitis: a multicenter observational study (CANAL study).

|Sep 13, 2026
Serum amyloid a as a high-resolution indicator of mucosal healing in ulcerative colitis.

|Sep 04, 2026
Serum soluble Fas levels and incidence of biliary tract cancer in a nested case-control study.

|Aug 30, 2026
Efficacy and safety of upadacitinib for Crohn's disease in patients in East Asia: a post hoc analysis of randomized phase 3 studies.

|Aug 19, 2026
Efficacy, Safety, and Pharmacokinetics of Upadacitinib Among Patients in East Asia With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Subanalysis of Randomized Phase 3 Studies.

|Jul 02, 2026
Long-term drug persistence and clinical outcomes of ustekinumab in Crohn's disease: a multicenter real-world study from the Hokkaido phoenix cohort.

Pageof 11

Frequent Collaborators

10 joint publications

Yoshihiro Yokoyama

8 joint publications

Kohei Wagatsuma

6 joint publications

Daisuke Hirayama

5 joint publications

Tomoya Iida